CD96 and acute myeloid leukemia: When comparing each combination independently, the only significant difference observed was an increase in the percentage of DNAM-1−TIGIT+TACTILE+ NKT-like cells (p = 0.002) in AML patients (Figure 2c and Figure 3c).